Nebenwirkungen · Benlysta
Benlysta 200 mg solution for injection in pre-filled pen. · Abschnitt 4.8 · PDF-Seite 11
HOS-123924 · Präparat HOS-095751
Infections 5- to 11-year-old group: infections were reported in 8/10 patients receiving Benlysta intravenously and 3/3 patients receiving placebo, and serious infections were reported in 1/10 patients receiving Benlysta intravenously and 2/3 patients receiving placebo (see section 4.4). 12- to 17-year-old group: infections were reported in 22/43 patients receiving Benlysta intravenously and 25/37 patients receiving placebo, and serious infections were reported in 3/43 patients receiving Benlysta intravenously and 3/37 patients receiving placebo. In the open-label extension phase there was one fatal infection in a patient receiving Benlysta intravenously.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-08T14:51:00Z · SHA-256 c5a3f583695e2640a8d21bbd8da1102adfb181d1d2a9c5afe0028436c8fd2402 · Passage f81b03ab78d2f5367cd94bdb206a5250760b31865aafe79db17e0bc076515534 · Zeichen 12347–13009 im Abschnitt